Claim extract · Listening Library

Dickinson / Third Wave: ibogaine and TBI narratives

LAST REVIEWED 2026-09-22 · MEDIA CLAIM EXTRACT · HIGH-CONFIDENCE LL

High-confidence Listening Library row (Third Wave #347, Jonathan Dickinson). Media — not a controlled TBI trial.

Listening Library source (outbound)

third-wave-347-dickinson-tbi — Third Wave episode. Confidence: high.

Claim: Ibogaine is a TBI treatment frontier based on veteran outcomes.
Primary: Cherian PMID 38182784 — open-label observational. TBI desk.
Claim: Brain-change / “reset” language.
Adjacency: imaging PMID 41687815; cortical PMID 41883580 — correlates ≠ proven efficacy.
Overclaim risk: “New treatment frontier” as settled proof.
Counter: Gorman PMID 42330793 · critique.
Theory bleed: Bicameral interpretations as clinical fact — bicameral check.

Media / observational adjacency — not proven TBI therapy; not FDA-approved.